{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:44:54Z","timestamp":1767703494111},"reference-count":50,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.vaccine.2010.06.020","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T00:27:35Z","timestamp":1277080055000},"page":"5924-5929","source":"Crossref","is-referenced-by-count":19,"title":["Protection against pneumonic plague following oral immunization with a non-replicating vaccine"],"prefix":"10.1016","volume":"28","author":[{"given":"Abby","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharine","family":"Bosio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Goodyear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schriefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Dow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9568 April","key":"10.1016\/j.vaccine.2010.06.020_bib1","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(07)60566-2","article-title":"Plague","volume":"369","author":"Prentice","year":"2007","journal-title":"Lancet"},{"issue":"Suppl. June","key":"10.1016\/j.vaccine.2010.06.020_bib2","first-page":"S78","article-title":"Yersinia pestis and the plague","volume":"119","author":"Rollins","year":"2003","journal-title":"American Journal of Clinical Pathology"},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.020_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/oxfordjournals.bmb.a011715","article-title":"Plague","volume":"54","author":"Titball","year":"1998","journal-title":"British Medical Bulletin"},{"issue":"6 June","key":"10.1016\/j.vaccine.2010.06.020_bib4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"21\u201322 June","key":"10.1016\/j.vaccine.2010.06.020_bib5","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/S0264-410X(03)00112-9","article-title":"Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague","volume":"21","author":"Garmory","year":"2003","journal-title":"Vaccine"},{"issue":"4 October","key":"10.1016\/j.vaccine.2010.06.020_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1365-2672.2001.01497.x","article-title":"Plague vaccine research and development","volume":"91","author":"Williamson","year":"2001","journal-title":"Journal of Applied Microbiology"},{"issue":"30 July","key":"10.1016\/j.vaccine.2010.06.020_bib7","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/S0264-410X(01)00163-3","article-title":"Vaccination against bubonic and pneumonic plague","volume":"19","author":"Titball","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.020_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-0-387-72124-8_38","article-title":"Protective immunity against plague","volume":"603","author":"Cornelius","year":"2007","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"4 April","key":"10.1016\/j.vaccine.2010.06.020_bib9","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/IAI.67.4.1922-1928.1999","article-title":"Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice","volume":"67","author":"Benner","year":"1999","journal-title":"Infection and Immunity"},{"issue":"1 January","key":"10.1016\/j.vaccine.2010.06.020_bib10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/IAI.71.1.374-383.2003","article-title":"Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen","volume":"71","author":"Grosfeld","year":"2003","journal-title":"Infection and Immunity"},{"issue":"3 September","key":"10.1016\/j.vaccine.2010.06.020_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/mpat.1997.0141","article-title":"Expression of an F1\/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague","volume":"23","author":"Leary","year":"1997","journal-title":"Microbial Pathogenesis"},{"issue":"13 March","key":"10.1016\/j.vaccine.2010.06.020_bib12","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.vaccine.2008.01.033","article-title":"Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague","volume":"26","author":"Zauberman","year":"2008","journal-title":"Vaccine"},{"issue":"1 January","key":"10.1016\/j.vaccine.2010.06.020_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/eji.200737799","article-title":"Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205\/CD205-positive mouse dendritic cells","volume":"38","author":"Do","year":"2008","journal-title":"European Journal of Immunology"},{"issue":"12 December","key":"10.1016\/j.vaccine.2010.06.020_bib14","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1128\/IAI.00699-08","article-title":"Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague","volume":"76","author":"Cornelius","year":"2008","journal-title":"Infection and Immunity"},{"issue":"1 July","key":"10.1016\/j.vaccine.2010.06.020_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4049\/jimmunol.181.1.109","article-title":"An age-old paradigm challenged: old baboons generate vigorous humoral immune responses to LcrV, a plague antigen","volume":"181","author":"Stacy","year":"2008","journal-title":"Journal of Immunology"},{"issue":"11\u201312 July","key":"10.1016\/j.vaccine.2010.06.020_bib16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"1 January","key":"10.1016\/j.vaccine.2010.06.020_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates","volume":"16","author":"Mizel","year":"2009","journal-title":"Clinical Vaccine Immunology"},{"issue":"1 January","key":"10.1016\/j.vaccine.2010.06.020_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7589\/0090-3558-44.1.1","article-title":"Vaccination with F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against plague upon oral challenge with Yersinia pestis","volume":"44","author":"Rocke","year":"2008","journal-title":"Journal of Wildlife Diseases"},{"issue":"1 April","key":"10.1016\/j.vaccine.2010.06.020_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clinical and Experimental Immunology"},{"issue":"10 October","key":"10.1016\/j.vaccine.2010.06.020_bib20","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1128\/IAI.00581-08","article-title":"A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague","volume":"76","author":"Yamanaka","year":"2008","journal-title":"Infection and Immunity"},{"issue":"5 May","key":"10.1016\/j.vaccine.2010.06.020_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/CVI.00447-08","article-title":"Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine","volume":"16","author":"Huang","year":"2009","journal-title":"Clinical Vaccine Immunology"},{"issue":"8 December","key":"10.1016\/j.vaccine.2010.06.020_bib22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/14712598.2.8.883","article-title":"Vaccines for category a bioterrorism diseases","volume":"2","author":"Lutwick","year":"2002","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"13 March","key":"10.1016\/j.vaccine.2010.06.020_bib23","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.vaccine.2005.11.047","article-title":"Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague","volume":"24","author":"Reed","year":"2006","journal-title":"Vaccine"},{"issue":"1\u20132 January","key":"10.1016\/j.vaccine.2010.06.020_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-3659(99)00197-2","article-title":"Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits","volume":"63","author":"Eyles","year":"2000","journal-title":"Journal of Controlled Release"},{"issue":"2 February","key":"10.1016\/j.vaccine.2010.06.020_bib25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"Honko","year":"2006","journal-title":"Infection and Immunity"},{"issue":"2 January","key":"10.1016\/j.vaccine.2010.06.020_bib26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4049\/jimmunol.178.2.1059","article-title":"Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague","volume":"178","author":"Yang","year":"2007","journal-title":"Journal of Immunology"},{"issue":"1 October","key":"10.1016\/j.vaccine.2010.06.020_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1574-695X.2007.00280.x","article-title":"A comparison of immunogenicity and protective immunity against experimental plague by intranasal and\/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen","volume":"51","author":"Liu","year":"2007","journal-title":"FEMS Immunology and Medical Microbiology"},{"key":"10.1016\/j.vaccine.2010.06.020_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-0-387-72124-8_36","article-title":"Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague","volume":"603","author":"Branger","year":"2007","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"Pt 6 June","key":"10.1016\/j.vaccine.2010.06.020_bib29","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1099\/mic.0.27959-0","article-title":"Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague","volume":"151","author":"Taylor","year":"2005","journal-title":"Microbiology (Reading, England)"},{"issue":"8 August","key":"10.1016\/j.vaccine.2010.06.020_bib30","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1128\/IAI.00034-08","article-title":"Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain","volume":"76","author":"Blisnick","year":"2008","journal-title":"Infection and Immunity"},{"issue":"12 June","key":"10.1016\/j.vaccine.2010.06.020_bib31","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.176.12.7335","article-title":"Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes","volume":"176","author":"Zaks","year":"2006","journal-title":"Journal of Immunology"},{"issue":"1 July","key":"10.1016\/j.vaccine.2010.06.020_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4049\/jimmunol.0803967","article-title":"Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation","volume":"183","author":"Takeda","year":"2009","journal-title":"Journal of Immunology"},{"issue":"7 July","key":"10.1016\/j.vaccine.2010.06.020_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nbt0797-647","article-title":"Improved DNA: liposome complexes for increased systemic delivery and gene expression","volume":"15","author":"Templeton","year":"1997","journal-title":"Nature Biotechnology"},{"issue":"30 July","key":"10.1016\/j.vaccine.2010.06.020_bib34","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1016\/j.vaccine.2006.12.001","article-title":"Induction of secretory immunity and memory at mucosal surfaces","volume":"25","author":"Brandtzaeg","year":"2007","journal-title":"Vaccine"},{"issue":"9 November","key":"10.1016\/j.vaccine.2010.06.020_bib35","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.4049\/jimmunol.179.9.5633","article-title":"Perspectives on mucosal vaccines: is mucosal tolerance a barrier?","volume":"179","author":"Mestecky","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.vaccine.2010.06.020_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune defense against pneumonic plague","volume":"225 (October)","author":"Smiley","year":"2008","journal-title":"Immunological Reviews"},{"issue":"11 November","key":"10.1016\/j.vaccine.2010.06.020_bib37","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infection and Immunity"},{"issue":"6 June","key":"10.1016\/j.vaccine.2010.06.020_bib38","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/IAI.00185-06","article-title":"Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection","volume":"74","author":"Parent","year":"2006","journal-title":"Infection and Immunity"},{"issue":"2 February","key":"10.1016\/j.vaccine.2010.06.020_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1357-4310(96)10058-7","article-title":"Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles","volume":"3","author":"O\u2019Hagan","year":"1997","journal-title":"Molecular Medicine Today"},{"issue":"August","key":"10.1016\/j.vaccine.2010.06.020_bib40","article-title":"Oral vaccine delivery\u2014new strategies and technologies","author":"Simerska","year":"2009","journal-title":"Current Drug Delivery"},{"issue":"4 July","key":"10.1016\/j.vaccine.2010.06.020_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1517\/17425247.4.4.323","article-title":"Oral vaccination: where we are?","volume":"4","author":"Silin","year":"2007","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"6 November","key":"10.1016\/j.vaccine.2010.06.020_bib42","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/17425247.3.6.747","article-title":"Delivery systems and adjuvants for oral vaccines","volume":"3","author":"Lavelle","year":"2006","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"2","key":"10.1016\/j.vaccine.2010.06.020_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0264-410X(93)90011-L","article-title":"Biodegradable microparticles for oral immunization","volume":"11","author":"O\u2019Hagan","year":"1993","journal-title":"Vaccine"},{"issue":"5 October","key":"10.1016\/j.vaccine.2010.06.020_bib44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0264-410X(89)90156-4","article-title":"Microparticles as potentially orally active immunological adjuvants","volume":"7","author":"O\u2019Hagan","year":"1989","journal-title":"Vaccine"},{"issue":"2 April","key":"10.1016\/j.vaccine.2010.06.020_bib45","first-page":"92","article-title":"Salmonella-based plague vaccines for bioterrorism","volume":"39","author":"Calhoun","year":"2006","journal-title":"Journal of Microbiology, Immunology, and Infection=Wei mian yu gan ran za zhi"},{"issue":"8 August","key":"10.1016\/j.vaccine.2010.06.020_bib46","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/IAI.00050-08","article-title":"Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts","volume":"76","author":"Arlen","year":"2008","journal-title":"Infection and Immunity"},{"issue":"2 January","key":"10.1016\/j.vaccine.2010.06.020_bib47","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.4049\/jimmunol.182.2.1211","article-title":"Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost","volume":"182","author":"Ramirez","year":"2009","journal-title":"Journal of Immunology"},{"issue":"50 November","key":"10.1016\/j.vaccine.2010.06.020_bib48","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1016\/j.vaccine.2008.09.031","article-title":"Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection","volume":"26","author":"Chattopadhyay","year":"2008","journal-title":"Vaccine"},{"issue":"2 February","key":"10.1016\/j.vaccine.2010.06.020_bib49","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.01529-06","article-title":"Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection","volume":"75","author":"Philipovskiy","year":"2007","journal-title":"Infection and Immunity"},{"issue":"52 December","key":"10.1016\/j.vaccine.2010.06.020_bib50","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1016\/j.vaccine.2008.09.063","article-title":"Antibodies and cytokines independently protect against pneumonic plague","volume":"26","author":"Kummer","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T23:19:56Z","timestamp":1591399196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10008182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":50,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0264410X10008182"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}